A nationwide study, released by Duke-NUS Medical School and Novartis, showed that migraines accounted for about $1 billion in economic cost in 2018. This was due to productivity loss as migraine sufferers were missing work and spending money treating their condition. The study found that migraine sufferers missed nearly 10 days of work on average in 2018. The productivity loss was equivalent to eight days when migraine patients were at work but performed poorly. Considerable sums of money go into the diagnosis and treatment of migraines.
- CNA, 28 December 2019